Respiratory syncytial virus (RSV) is a highly contagious virus that primarily affects the respiratory tract (lungs and respiratory passages). It is suitable for babies, toddlers and seniors

Common cause of respiratory and lower respiratory infections. Infection can lead to serious complications such as pneumonia and bronchiolitis. Currently, there is no specific treatment for RSV. However, symptoms can be managed with supportive care. Preventive measures include good hygiene, such as frequent hand washing, and avoiding close contact with infected people. RSV diagnostic tests come in a variety of formats, including laboratory-based tests, rapid antigen tests, and molecular tests. Laboratory-based tests, such as ELISA and PCR, provide highly accurate results. Rapid Antigen Diagnostic Tests (RADTs) provide rapid results and are used in point-of-care settings. Molecular detection is highly accurate and widely used in hospitals and diagnostic centers.

The global Respiratory Syncytial Virus Diagnostic Tests market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Respiratory Syncytial Virus Diagnostic Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Syncytial Virus Diagnostic Tests.

Report Scope

The Respiratory Syncytial Virus Diagnostic Tests market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Respiratory Syncytial Virus Diagnostic Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Respiratory Syncytial Virus Diagnostic Tests manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Respiratory Syncytial Virus Diagnostic Tests Market Report

Report Metric	Details
Report Name	Respiratory Syncytial Virus Diagnostic Tests Market
CAGR	5%
Segment by Type	Detection Box Instrument
Segment by Application	Hospital Specialist Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Hologic, Inc., Luminex Corporation, Agilent Technologies, Inc., Cepheid (Danaher Corporation), DiaSorin S.p.A.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Respiratory Syncytial Virus Diagnostic Tests manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Respiratory Syncytial Virus Diagnostic Tests in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Respiratory Syncytial Virus Diagnostic Tests Market report?

Ans: The main players in the Respiratory Syncytial Virus Diagnostic Tests Market are F. Hoffmann-La Roche AG, Abbott, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), QuidelOrtho Corporation, Hologic, Inc., Luminex Corporation, Agilent Technologies, Inc., Cepheid (Danaher Corporation), DiaSorin S.p.A.

What are the Application segmentation covered in the Respiratory Syncytial Virus Diagnostic Tests Market report?

Ans: The Applications covered in the Respiratory Syncytial Virus Diagnostic Tests Market report are Hospital, Specialist Clinic, Other

What are the Type segmentation covered in the Respiratory Syncytial Virus Diagnostic Tests Market report?

Ans: The Types covered in the Respiratory Syncytial Virus Diagnostic Tests Market report are Detection Box, Instrument

1 Respiratory Syncytial Virus Diagnostic Tests Market Overview

1.1 Product Overview and Scope of Respiratory Syncytial Virus Diagnostic Tests

1.2 Respiratory Syncytial Virus Diagnostic Tests Segment by Type

1.2.1 Global Respiratory Syncytial Virus Diagnostic Tests Market Value Comparison by Type (2024-2030)

1.2.2 Detection Box

1.2.3 Instrument

1.3 Respiratory Syncytial Virus Diagnostic Tests Segment by Application

1.3.1 Global Respiratory Syncytial Virus Diagnostic Tests Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Specialist Clinic

1.3.4 Other

1.4 Global Respiratory Syncytial Virus Diagnostic Tests Market Size Estimates and Forecasts

1.4.1 Global Respiratory Syncytial Virus Diagnostic Tests Revenue 2019-2030

1.4.2 Global Respiratory Syncytial Virus Diagnostic Tests Sales 2019-2030

1.4.3 Global Respiratory Syncytial Virus Diagnostic Tests Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Respiratory Syncytial Virus Diagnostic Tests Market Competition by Manufacturers

2.1 Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Manufacturers (2019-2024)

2.2 Global Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Respiratory Syncytial Virus Diagnostic Tests Average Price by Manufacturers (2019-2024)

2.4 Global Respiratory Syncytial Virus Diagnostic Tests Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Respiratory Syncytial Virus Diagnostic Tests, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Respiratory Syncytial Virus Diagnostic Tests, Product Type & Application

2.7 Respiratory Syncytial Virus Diagnostic Tests Market Competitive Situation and Trends

2.7.1 Respiratory Syncytial Virus Diagnostic Tests Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Respiratory Syncytial Virus Diagnostic Tests Players Market Share by Revenue

2.7.3 Global Respiratory Syncytial Virus Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Respiratory Syncytial Virus Diagnostic Tests Retrospective Market Scenario by Region

3.1 Global Respiratory Syncytial Virus Diagnostic Tests Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Respiratory Syncytial Virus Diagnostic Tests Global Respiratory Syncytial Virus Diagnostic Tests Sales by Region: 2019-2030

3.2.1 Global Respiratory Syncytial Virus Diagnostic Tests Sales by Region: 2019-2024

3.2.2 Global Respiratory Syncytial Virus Diagnostic Tests Sales by Region: 2025-2030

3.3 Global Respiratory Syncytial Virus Diagnostic Tests Global Respiratory Syncytial Virus Diagnostic Tests Revenue by Region: 2019-2030

3.3.1 Global Respiratory Syncytial Virus Diagnostic Tests Revenue by Region: 2019-2024

3.3.2 Global Respiratory Syncytial Virus Diagnostic Tests Revenue by Region: 2025-2030

3.4 North America Respiratory Syncytial Virus Diagnostic Tests Market Facts & Figures by Country

3.4.1 North America Respiratory Syncytial Virus Diagnostic Tests Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Respiratory Syncytial Virus Diagnostic Tests Sales by Country (2019-2030)

3.4.3 North America Respiratory Syncytial Virus Diagnostic Tests Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Respiratory Syncytial Virus Diagnostic Tests Market Facts & Figures by Country

3.5.1 Europe Respiratory Syncytial Virus Diagnostic Tests Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Respiratory Syncytial Virus Diagnostic Tests Sales by Country (2019-2030)

3.5.3 Europe Respiratory Syncytial Virus Diagnostic Tests Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Market Facts & Figures by Country

3.6.1 Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Sales by Country (2019-2030)

3.6.3 Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Respiratory Syncytial Virus Diagnostic Tests Market Facts & Figures by Country

3.7.1 Latin America Respiratory Syncytial Virus Diagnostic Tests Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Respiratory Syncytial Virus Diagnostic Tests Sales by Country (2019-2030)

3.7.3 Latin America Respiratory Syncytial Virus Diagnostic Tests Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Respiratory Syncytial Virus Diagnostic Tests Market Facts & Figures by Country

3.8.1 Middle East and Africa Respiratory Syncytial Virus Diagnostic Tests Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Respiratory Syncytial Virus Diagnostic Tests Sales by Country (2019-2030)

3.8.3 Middle East and Africa Respiratory Syncytial Virus Diagnostic Tests Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Respiratory Syncytial Virus Diagnostic Tests Sales by Type (2019-2030)

4.1.1 Global Respiratory Syncytial Virus Diagnostic Tests Sales by Type (2019-2024)

4.1.2 Global Respiratory Syncytial Virus Diagnostic Tests Sales by Type (2025-2030)

4.1.3 Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Type (2019-2030)

4.2 Global Respiratory Syncytial Virus Diagnostic Tests Revenue by Type (2019-2030)

4.2.1 Global Respiratory Syncytial Virus Diagnostic Tests Revenue by Type (2019-2024)

4.2.2 Global Respiratory Syncytial Virus Diagnostic Tests Revenue by Type (2025-2030)

4.2.3 Global Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Type (2019-2030)

4.3 Global Respiratory Syncytial Virus Diagnostic Tests Price by Type (2019-2030)

5 Segment by Application

5.1 Global Respiratory Syncytial Virus Diagnostic Tests Sales by Application (2019-2030)

5.1.1 Global Respiratory Syncytial Virus Diagnostic Tests Sales by Application (2019-2024)

5.1.2 Global Respiratory Syncytial Virus Diagnostic Tests Sales by Application (2025-2030)

5.1.3 Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Application (2019-2030)

5.2 Global Respiratory Syncytial Virus Diagnostic Tests Revenue by Application (2019-2030)

5.2.1 Global Respiratory Syncytial Virus Diagnostic Tests Revenue by Application (2019-2024)

5.2.2 Global Respiratory Syncytial Virus Diagnostic Tests Revenue by Application (2025-2030)

5.2.3 Global Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Application (2019-2030)

5.3 Global Respiratory Syncytial Virus Diagnostic Tests Price by Application (2019-2030)

6 Key Companies Profiled

6.1 F. Hoffmann-La Roche AG

6.1.1 F. Hoffmann-La Roche AG Corporation Information

6.1.2 F. Hoffmann-La Roche AG Description and Business Overview

6.1.3 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

6.1.4 F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Tests Product Portfolio

6.1.5 F. Hoffmann-La Roche AG Recent Developments/Updates

6.2 Abbott

6.2.1 Abbott Corporation Information

6.2.2 Abbott Description and Business Overview

6.2.3 Abbott Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Abbott Respiratory Syncytial Virus Diagnostic Tests Product Portfolio

6.2.5 Abbott Recent Developments/Updates

6.3 Thermo Fisher Scientific

6.3.1 Thermo Fisher Scientific Corporation Information

6.3.2 Thermo Fisher Scientific Description and Business Overview

6.3.3 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Tests Product Portfolio

6.3.5 Thermo Fisher Scientific Recent Developments/Updates

6.4 BD (Becton, Dickinson and Company)

6.4.1 BD (Becton, Dickinson and Company) Corporation Information

6.4.2 BD (Becton, Dickinson and Company) Description and Business Overview

6.4.3 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

6.4.4 BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Tests Product Portfolio

6.4.5 BD (Becton, Dickinson and Company) Recent Developments/Updates

6.5 QuidelOrtho Corporation

6.5.1 QuidelOrtho Corporation Corporation Information

6.5.2 QuidelOrtho Corporation Description and Business Overview

6.5.3 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

6.5.4 QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Tests Product Portfolio

6.5.5 QuidelOrtho Corporation Recent Developments/Updates

6.6 Hologic, Inc.

6.6.1 Hologic, Inc. Corporation Information

6.6.2 Hologic, Inc. Description and Business Overview

6.6.3 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Hologic, Inc. Respiratory Syncytial Virus Diagnostic Tests Product Portfolio

6.6.5 Hologic, Inc. Recent Developments/Updates

6.7 Luminex Corporation

6.6.1 Luminex Corporation Corporation Information

6.6.2 Luminex Corporation Description and Business Overview

6.6.3 Luminex Corporation Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Luminex Corporation Respiratory Syncytial Virus Diagnostic Tests Product Portfolio

6.7.5 Luminex Corporation Recent Developments/Updates

6.8 Agilent Technologies, Inc.

6.8.1 Agilent Technologies, Inc. Corporation Information

6.8.2 Agilent Technologies, Inc. Description and Business Overview

6.8.3 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Tests Product Portfolio

6.8.5 Agilent Technologies, Inc. Recent Developments/Updates

6.9 Cepheid (Danaher Corporation)

6.9.1 Cepheid (Danaher Corporation) Corporation Information

6.9.2 Cepheid (Danaher Corporation) Description and Business Overview

6.9.3 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Tests Product Portfolio

6.9.5 Cepheid (Danaher Corporation) Recent Developments/Updates

6.10 DiaSorin S.p.A.

6.10.1 DiaSorin S.p.A. Corporation Information

6.10.2 DiaSorin S.p.A. Description and Business Overview

6.10.3 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Tests Sales, Revenue and Gross Margin (2019-2024)

6.10.4 DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Tests Product Portfolio

6.10.5 DiaSorin S.p.A. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Respiratory Syncytial Virus Diagnostic Tests Industry Chain Analysis

7.2 Respiratory Syncytial Virus Diagnostic Tests Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Respiratory Syncytial Virus Diagnostic Tests Production Mode & Process

7.4 Respiratory Syncytial Virus Diagnostic Tests Sales and Marketing

7.4.1 Respiratory Syncytial Virus Diagnostic Tests Sales Channels

7.4.2 Respiratory Syncytial Virus Diagnostic Tests Distributors

7.5 Respiratory Syncytial Virus Diagnostic Tests Customers

8 Respiratory Syncytial Virus Diagnostic Tests Market Dynamics

8.1 Respiratory Syncytial Virus Diagnostic Tests Industry Trends

8.2 Respiratory Syncytial Virus Diagnostic Tests Market Drivers

8.3 Respiratory Syncytial Virus Diagnostic Tests Market Challenges

8.4 Respiratory Syncytial Virus Diagnostic Tests Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

F. Hoffmann-La Roche AG

Abbott

Thermo Fisher Scientific

BD (Becton, Dickinson and Company)

QuidelOrtho Corporation

Hologic Inc

Luminex Corporation

Agilent Technologies Inc

Cepheid(Danaher Corporation)

DiaSorin

List of Tables

Table 1. Global Respiratory Syncytial Virus Diagnostic Tests Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Respiratory Syncytial Virus Diagnostic Tests Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Respiratory Syncytial Virus Diagnostic Tests Market Competitive Situation by Manufacturers in 2023

Table 4. Global Respiratory Syncytial Virus Diagnostic Tests Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Respiratory Syncytial Virus Diagnostic Tests Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Respiratory Syncytial Virus Diagnostic Tests Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Respiratory Syncytial Virus Diagnostic Tests Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Respiratory Syncytial Virus Diagnostic Tests, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Respiratory Syncytial Virus Diagnostic Tests, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Respiratory Syncytial Virus Diagnostic Tests, Product Type & Application

Table 12. Global Key Manufacturers of Respiratory Syncytial Virus Diagnostic Tests, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Respiratory Syncytial Virus Diagnostic Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Diagnostic Tests as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Respiratory Syncytial Virus Diagnostic Tests Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Respiratory Syncytial Virus Diagnostic Tests Sales by Region (2019-2024) & (K Units)

Table 18. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Region (2019-2024)

Table 19. Global Respiratory Syncytial Virus Diagnostic Tests Sales by Region (2025-2030) & (K Units)

Table 20. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Region (2025-2030)

Table 21. Global Respiratory Syncytial Virus Diagnostic Tests Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Region (2019-2024)

Table 23. Global Respiratory Syncytial Virus Diagnostic Tests Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Region (2025-2030)

Table 25. North America Respiratory Syncytial Virus Diagnostic Tests Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Respiratory Syncytial Virus Diagnostic Tests Sales by Country (2019-2024) & (K Units)

Table 27. North America Respiratory Syncytial Virus Diagnostic Tests Sales by Country (2025-2030) & (K Units)

Table 28. North America Respiratory Syncytial Virus Diagnostic Tests Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Respiratory Syncytial Virus Diagnostic Tests Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Respiratory Syncytial Virus Diagnostic Tests Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Respiratory Syncytial Virus Diagnostic Tests Sales by Country (2019-2024) & (K Units)

Table 32. Europe Respiratory Syncytial Virus Diagnostic Tests Sales by Country (2025-2030) & (K Units)

Table 33. Europe Respiratory Syncytial Virus Diagnostic Tests Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Respiratory Syncytial Virus Diagnostic Tests Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Respiratory Syncytial Virus Diagnostic Tests Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Respiratory Syncytial Virus Diagnostic Tests Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Respiratory Syncytial Virus Diagnostic Tests Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Respiratory Syncytial Virus Diagnostic Tests Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Respiratory Syncytial Virus Diagnostic Tests Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Respiratory Syncytial Virus Diagnostic Tests Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Respiratory Syncytial Virus Diagnostic Tests Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Respiratory Syncytial Virus Diagnostic Tests Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Respiratory Syncytial Virus Diagnostic Tests Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Respiratory Syncytial Virus Diagnostic Tests Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Respiratory Syncytial Virus Diagnostic Tests Sales (K Units) by Type (2019-2024)

Table 51. Global Respiratory Syncytial Virus Diagnostic Tests Sales (K Units) by Type (2025-2030)

Table 52. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Type (2019-2024)

Table 53. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Type (2025-2030)

Table 54. Global Respiratory Syncytial Virus Diagnostic Tests Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Respiratory Syncytial Virus Diagnostic Tests Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Type (2019-2024)

Table 57. Global Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Type (2025-2030)

Table 58. Global Respiratory Syncytial Virus Diagnostic Tests Price (US$/Unit) by Type (2019-2024)

Table 59. Global Respiratory Syncytial Virus Diagnostic Tests Price (US$/Unit) by Type (2025-2030)

Table 60. Global Respiratory Syncytial Virus Diagnostic Tests Sales (K Units) by Application (2019-2024)

Table 61. Global Respiratory Syncytial Virus Diagnostic Tests Sales (K Units) by Application (2025-2030)

Table 62. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Application (2019-2024)

Table 63. Global Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Application (2025-2030)

Table 64. Global Respiratory Syncytial Virus Diagnostic Tests Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Respiratory Syncytial Virus Diagnostic Tests Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Application (2019-2024)

Table 67. Global Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Application (2025-2030)

Table 68. Global Respiratory Syncytial Virus Diagnostic Tests Price (US$/Unit) by Application (2019-2024)

Table 69. Global Respiratory Syncytial Virus Diagnostic Tests Price (US$/Unit) by Application (2025-2030)

Table 70. F. Hoffmann-La Roche AG Corporation Information

Table 71. F. Hoffmann-La Roche AG Description and Business Overview

Table 72. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. F. Hoffmann-La Roche AG Respiratory Syncytial Virus Diagnostic Tests Product

Table 74. F. Hoffmann-La Roche AG Recent Developments/Updates

Table 75. Abbott Corporation Information

Table 76. Abbott Description and Business Overview

Table 77. Abbott Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Abbott Respiratory Syncytial Virus Diagnostic Tests Product

Table 79. Abbott Recent Developments/Updates

Table 80. Thermo Fisher Scientific Corporation Information

Table 81. Thermo Fisher Scientific Description and Business Overview

Table 82. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Thermo Fisher Scientific Respiratory Syncytial Virus Diagnostic Tests Product

Table 84. Thermo Fisher Scientific Recent Developments/Updates

Table 85. BD (Becton, Dickinson and Company) Corporation Information

Table 86. BD (Becton, Dickinson and Company) Description and Business Overview

Table 87. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. BD (Becton, Dickinson and Company) Respiratory Syncytial Virus Diagnostic Tests Product

Table 89. BD (Becton, Dickinson and Company) Recent Developments/Updates

Table 90. QuidelOrtho Corporation Corporation Information

Table 91. QuidelOrtho Corporation Description and Business Overview

Table 92. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. QuidelOrtho Corporation Respiratory Syncytial Virus Diagnostic Tests Product

Table 94. QuidelOrtho Corporation Recent Developments/Updates

Table 95. Hologic, Inc. Corporation Information

Table 96. Hologic, Inc. Description and Business Overview

Table 97. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Hologic, Inc. Respiratory Syncytial Virus Diagnostic Tests Product

Table 99. Hologic, Inc. Recent Developments/Updates

Table 100. Luminex Corporation Corporation Information

Table 101. Luminex Corporation Description and Business Overview

Table 102. Luminex Corporation Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Luminex Corporation Respiratory Syncytial Virus Diagnostic Tests Product

Table 104. Luminex Corporation Recent Developments/Updates

Table 105. Agilent Technologies, Inc. Corporation Information

Table 106. Agilent Technologies, Inc. Description and Business Overview

Table 107. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Agilent Technologies, Inc. Respiratory Syncytial Virus Diagnostic Tests Product

Table 109. Agilent Technologies, Inc. Recent Developments/Updates

Table 110. Cepheid (Danaher Corporation) Corporation Information

Table 111. Cepheid (Danaher Corporation) Description and Business Overview

Table 112. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Cepheid (Danaher Corporation) Respiratory Syncytial Virus Diagnostic Tests Product

Table 114. Cepheid (Danaher Corporation) Recent Developments/Updates

Table 115. DiaSorin S.p.A. Corporation Information

Table 116. DiaSorin S.p.A. Description and Business Overview

Table 117. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Tests Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. DiaSorin S.p.A. Respiratory Syncytial Virus Diagnostic Tests Product

Table 119. DiaSorin S.p.A. Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Respiratory Syncytial Virus Diagnostic Tests Distributors List

Table 123. Respiratory Syncytial Virus Diagnostic Tests Customers List

Table 124. Respiratory Syncytial Virus Diagnostic Tests Market Trends

Table 125. Respiratory Syncytial Virus Diagnostic Tests Market Drivers

Table 126. Respiratory Syncytial Virus Diagnostic Tests Market Challenges

Table 127. Respiratory Syncytial Virus Diagnostic Tests Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Respiratory Syncytial Virus Diagnostic Tests

Figure 2. Global Respiratory Syncytial Virus Diagnostic Tests Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Respiratory Syncytial Virus Diagnostic Tests Market Share by Type in 2023 & 2030

Figure 4. Detection Box Product Picture

Figure 5. Instrument Product Picture

Figure 6. Global Respiratory Syncytial Virus Diagnostic Tests Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Respiratory Syncytial Virus Diagnostic Tests Market Share by Application in 2023 & 2030

Figure 8. Hospital

Figure 9. Specialist Clinic

Figure 10. Other

Figure 11. Global Respiratory Syncytial Virus Diagnostic Tests Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Respiratory Syncytial Virus Diagnostic Tests Market Size (2019-2030) & (US$ Million)

Figure 13. Global Respiratory Syncytial Virus Diagnostic Tests Sales (2019-2030) & (K Units)

Figure 14. Global Respiratory Syncytial Virus Diagnostic Tests Average Price (US$/Unit) & (2019-2030)

Figure 15. Respiratory Syncytial Virus Diagnostic Tests Report Years Considered

Figure 16. Respiratory Syncytial Virus Diagnostic Tests Sales Share by Manufacturers in 2023

Figure 17. Global Respiratory Syncytial Virus Diagnostic Tests Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Respiratory Syncytial Virus Diagnostic Tests Players: Market Share by Revenue in 2023

Figure 19. Respiratory Syncytial Virus Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Respiratory Syncytial Virus Diagnostic Tests Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Country (2019-2030)

Figure 22. North America Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Country (2019-2030)

Figure 23. United States Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Country (2019-2030)

Figure 26. Europe Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Country (2019-2030)

Figure 27. Germany Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Region (2019-2030)

Figure 34. China Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Country (2019-2030)

Figure 42. Latin America Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Country (2019-2030)

Figure 43. Mexico Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Respiratory Syncytial Virus Diagnostic Tests Sales Market Share by Country (2019-2030)

Figure 47. Middle East & Africa Respiratory Syncytial Virus Diagnostic Tests Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Respiratory Syncytial Virus Diagnostic Tests Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Respiratory Syncytial Virus Diagnostic Tests by Type (2019-2030)

Figure 52. Global Revenue Market Share of Respiratory Syncytial Virus Diagnostic Tests by Type (2019-2030)

Figure 53. Global Respiratory Syncytial Virus Diagnostic Tests Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Respiratory Syncytial Virus Diagnostic Tests by Application (2019-2030)

Figure 55. Global Revenue Market Share of Respiratory Syncytial Virus Diagnostic Tests by Application (2019-2030)

Figure 56. Global Respiratory Syncytial Virus Diagnostic Tests Price (US$/Unit) by Application (2019-2030)

Figure 57. Respiratory Syncytial Virus Diagnostic Tests Value Chain

Figure 58. Respiratory Syncytial Virus Diagnostic Tests Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions